Disulfiram Tablets (Teva) – Missing Cotton Coil (2013)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Disulfiram Tablets USP 250 mg, 100 tablet bottle, Rx only, Manufactured for TEVA Pharmaceuticals, USA, Sellersville, PA --- NDC 0093-5035-01
Brand
Teva Pharmaceuticals USA, Inc.
Lot Codes / Batch Numbers
NDC 0093-5035-01, Lot numbers 14064211A, exp 3/2014, 14064311A, exp 3/2014, 14064411A, exp 3/2014, 14064511A, exp 3/2014, 14090312A, exp 4/2015, 14092512A, exp 4/2015, 14092712A, exp 4/2015, 14094612A, exp 4/2015, 14099412A, exp 4/2015, 14099612B, exp 4/2015, 14099712A, exp 5/2015, 14110111A, exp 5/2014, 14110211A, exp 5/2014, 14110311A, exp 5/2014, 14110411A, exp 5/2014 and 34090212A, exp 4/2015.
Products Sold
NDC 0093-5035-01, Lot numbers 14064211A, exp 3/2014; 14064311A, exp 3/2014; 14064411A, exp 3/2014; 14064511A, exp 3/2014; 14090312A, exp 4/2015; 14092512A, exp 4/2015; 14092712A, exp 4/2015; 14094612A, exp 4/2015; 14099412A, exp 4/2015; 14099612B, exp 4/2015; 14099712A, exp 5/2015; 14110111A, exp 5/2014; 14110211A, exp 5/2014; 14110311A, exp 5/2014; 14110411A, exp 5/2014 and 34090212A, exp 4/2015.
Teva Pharmaceuticals USA, Inc. is recalling Disulfiram Tablets USP 250 mg, 100 tablet bottle, Rx only, Manufactured for TEVA Pharmaceuticals, US due to CGMP Deviation; cotton coil is missing in some packaged bottles. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
CGMP Deviation; cotton coil is missing in some packaged bottles
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026